The Cancer Genetics Network (CGN) was a national research network sponsored by the National Cancer Institute, dedicated to investigating the genetic basis of cancer susceptibility and integrating this knowledge into medical practice. Comprised of 14 clinical research centers, a data coordinating center, and an informatics group, the CGN enrolled over 26,000 participants and conducted 10 research studies, resulting in the publication of more than 100 papers.
Collaborating with renowned institutions such as Johns Hopkins University and the University of Texas MD Anderson Cancer Center, the CGN aimed to address the psychosocial issues associated with cancer risk through screening studies, minority recruitment strategies, and behavioral effects research. As an NIH-funded project of Massachusetts General Hospital, a Harvard Medical School teaching affiliate, the CGN played a vital role in advancing our understanding of cancer genetics and its implications for medical practice.
Generated from the website